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Section S-1: Materials and instruments
All chemicals were obtained from commercial suppliers and used without purification.
Ultrapure water was utilized from a Milli-Q reference system (Millipore). The field emission scanning electron microscope (SEM) results were obtained on JSM-6700F (JEOL). Transmission electron microscope (TEM) images were recorded using JEM-2100F (JEOL). The atomic force microscopy (AFM) images were gained on a Multimode 8 (Bruker) with ScanAsyst. Powder X-ray diffraction (PXRD) patterns were recorded on Phillips PANalytical diffractometer for Cu K α radiation (α = 1.5406 Å), with a scan speed of 1° min -1 and a step size of 0.02° in 2θ and Rigaku MicroMax 007HF diffractometer respectively. Samples were observed using a continuous 2θ scan from 1.0-40º. Fourier transform infrared (FTIR) spectra were recorded on TENSOR27 spectrometer (Bruker) in the 500-4000 cm -1 . Dynamic light scattering (DLS) measurements were made on a Zetasizer 3000Hs (Malvern). The UV-vis absorption spectra were collected on a UV-2450 UV-vis spectrometer (Shimadzu). Fluoromax-4 spectrofluorometer (HORIBA JobinYvon) was used to collect the fluorescence signal with the slits set at 5.0 nm. One-photon (OP) and two-photon (TP) fluorescence bioimages of live tumor cells and tissues were picked up through an Olympus FV1000-MPE multiphoton laser scanning confocal microscope (Olympus).
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Section S-2: Experimental Section
Synthesis of 1,3,5-triformylphloroglucinol (Tp): 1,3,5-Triformylphloroglucinol was synthesized according to a previous literature (Scheme S1). 1 Briefly, hexamethylenetetramine (7.4 g, 52.8 mmol) and dried phloroglucinol (3.0 g, 23.8 mmol) were mixed in two-neck round-bottom flask and trifluoroacetic acid (TFA, 45 mL) was added with ice-bath under nitrogen atmosphere. The solution was then allowed to reflux at 100 ˚C for 2.5 h. After that time period, 3 M HCl (100 mL) was added slowly and the solution was further refluxed for another 1 h. After cooling to room temperature, the solution was filtered through Celite. Obtained filtrate was extracted with dichloromethane (4 × 100 mL) and dried over anhydrous Na 2 SO 4 . The obtained extract was concentrated and purified by using hot ethanol to yield an off-white powder.
Scheme S1. Synthetic scheme of Tp.
Synthesis of 4-Aminosalicylhydrazide (ASH): 4-Aminosalicylhydrazide was
synthesized according to a previous literature with a two-step reaction (Scheme S2). 1 Synthesis of 1: 4-Aminosalicylic acid (5 g, 32.7 mmol) was dissolved in dried ethanol (50 mL) and conc. H 2 SO 4 (3 mL) was added dropwise with ice-bath. Then the resultant mixture was refluxed for 3 h under nitrogen atmosphere. After cooling to room temperature, about 30 mL of ethanol was evaporated and the obtained solution was extracted with dichloromethane (3 × 30 mL) and dried over anhydrous Na 2 SO 4 . The compound 1 was collected by evaporation of dichloromethane under vacuum.
Synthesis of ASH:
The compound 1 (2.5 g, 13.8 mmol) was added to about 10 mL of 80% hydrazine monohydrate and then the resultant mixture was refluxed for overnight under nitrogen atmosphere. After evaporation of excess hydrazine monohydrate, the S5 product was added to ice cold distilled water, followed by extraction in ethyl acetate.
The compound ASH was collected by evaporation of ethyl acetate under vacuum. Scheme S2. Synthetic scheme of ASH.
Synthesis of fluorescent probe NPHS:
The compound NPHS was synthesized according to our optimized synthetic methodology with a three-step reaction (Scheme S3).
Synthesis of 2:
4-Bromo-1,8-naphthalicanhydride (2.77 g, 10 mmol) was dissolved in DMF (60 mL) and sodium azide (1.95 g, 30 mmol) was dissolved in water (2 mL). The reaction mixture was protected from light and heated to 80 °C for 2 h, and the solution was poured into ice water. The precipitated yellow solid was filtered to give the compound 2.
Synthesis of 3:
The reaction mixture of compound 2 (0.239 g, 1 mmol), 4-aminobutanoic acid (0.412 g, 4 mmol), ethanol (30 ml),water (6 ml) was protected from light and heated to 90 °C for 3 h. The mixture was filtered, then dried in the oven to give the compound 3.
Synthesis of NPHS:
To a DMF solution (10 ml) of compound 3 (0.324 g, 1 mmol) and EDC·HCl (0.250 g, 1.3 mmol), NHS (0.250 g, 1.3 mmol) were added at room temperature. Activation of compound 3 was carried out for 4 h under dark condition, then 3-aminopropyltriethoxysilane (APTES, 0.442 g, 2 mmol) was added and the reaction mixture was stirred for overnight under dark. The crude product was purified by preparative thin layer chromatography to yield pure NHS.
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Scheme S3. Synthetic scheme of NPHS.
Synthesis of fluorescent probe CNPHS for comparison:
The compound CNPHS was synthesized according to a previous literature (Scheme S4). 2 Briefly, n-butylamine (0.5 mL) and compound 2 (0.239 g, 1 mmol) were dissolved in methanol. The reaction mixture was protected from light and heated to reflux for 5 h. After cooling to room temperature, the solution was filtered and the solid residue was washed with methanol to obtain CNPHS. Scheme S4. Synthetic scheme of CNPHS.
Synthesis of COFs and Post-synthetic Modifications:
The COF TpASH was synthesized according to a previous literature by salt-mediated Schiff base condensation reaction (Scheme S5). 1 The post-synthetic modifications were carried out on TpASH via two step to yield bulk TP fluorescent COF TpASH-NPHS (Scheme S5).
Synthesis of TpASH: ASH (75.15 mg, 0.45 mmol) and p-toluenesulphonic acid (PTSA) (500 mg) were mixed in a pestle mortar for about 10 min to obtain a sticky salt.
And then Tp (63 mg, 0.3 mmol) and de-ionized water were added and mixed. The mixture was then tranferred to a glass vial and kept in 90 ˚C for 12 h. After cooling to room temperature, the resultant product was washed extensively with hot water, DMAc and acetone respectively. The product was dried at 90 ˚C for overnight to obtain brown S7 colored COFs.
Synthesis of TpASH-Glc: TpASH-Glc was synthesized according to a previous literature. 1 Briefly, TpASH (60 mg) was dispersed in 0.1 M NaHCO 3 solution (25 mL) for 5 min by sonication and glycidol (Glc, 750 µL) was added and the reaction mixture was kept under reflux for 24 h. After cooling to room temperature, the resultant product was washed extensively with ethanol and dried at 60 ˚C for overnight.
Synthesis of TpASH-NPHS:
TpASH-Glc (50 mg) was dispersed in toluene (25 mL) by sonication under nitrogen atmosphere and NPHS (50 mg) was added. Then the reaction mixture was refluxed under dark for overnight. After cooling to room temperature, the resultant product was washed extensively with ethanol, DMAc and acetone respectively. Finally the product was dried at 60 ˚C for overnight. Then the cells were used a multimode microplate to determine the cell viability.
Imaging of H 2 S in Live Cells. The cells (HeLa or HepG2) were first incubated with
DMEM culture medium in a 30 mm optical culture dish for 24 h at 37 °C, then culture medium was replaced and TpASH-NPHS (100 μg/mL) was added into the fresh culture medium for incubating another 2 h at 37 °C. After washing with DPBS for three times, the cells were incubated with different concentrations of NaHS solution for additional 40 min at 37 °C. After washing with DPBS for three times, OP and TP excited fluorescence imaging of the cells was recorded with magnification at 60 ×. The TP images were collected at 460-560 nm upon excitation at 820 nm with femtosecond pulses. The OP images were collected at 500-600 nm upon excitation at 405 nm.
Endocytosis pathway detection. The HepG2 cells were incubated with DMEM for 24
h. Then, serum-free DMEM as the control and one of the following inhibitors including chlorpromazine hydrochloride (5 μg/mL), genistein (50 μg/mL), or methyl-β-cyclodextrin (5 mg/mL) dissolved in serum-free DMEM were used to pretreat the cells at 37 °C for 2 h. Then, the medium in each well was discarded and replaced with fresh medium containing TpASH-NPHS (100 μg/mL) and the corresponding inhibitor with incubation at 37 ℃ for another 2h. And 4 °C culturing was used to inhibit energy-S10 dependent mechanisms. After washing with DPBS for three times, the cells were incubated with NaHS solution for additional 40 min.
Imaging of H 2 S in Deep Tissues. The HeLa and HepG2 tumor tissues slices with a thickness of 500 μm were prepared from nude mice. The tissue slices were incubated with TpASH-NPHS at 37 °C for 2 h. Washed with DPBS three times, the tissue slices were co-incubated 100 μM NaHS solution at 37 °C for additional 40 min. The tissue slices were incubated without NaHS as control. Then the TP fluorescence microscopy images were collected after washed with DPBS three times.
Hypoxia Treatment. Hypoxia treatments were carried out in the AnaeroPack system for cell culture (Mitsubishi Gas Chemical Co., Tokyo, Japan). For experiments at <0.1% O 2 cells were incubated on optical culture dish. Unless otherwise specified, CNPHS (1 μM) and TpASH-NPHS (100 μg/mL) was utilized under hypoxia for 3h. The loading concentration of NPHS in TpASH-NPHS (100 μg/mL) was 1.05 μM. TpASH-NPHS (100 μg/mL) after additional NaHS (100 μM). λ ex = 405 nm, λ em = 500-600 nm. Scale bar: 20 μm. 
